The paradigm shift in cervical adenocarcinoma
نویسندگان
چکیده
منابع مشابه
Paradigm Shift
A paradigm shift, suggested by Thomas Kuhn [1], is not just a small change in science, or the modification of a theory. It is a scientific revolution and completely changes the way in which science looks at the world. It often dictates how the public looks at the world. For example, Darwin's theories [2] were intensely debated by scientists and theologians. This debate spilled over into the pub...
متن کاملFat Grafting Technique, A Paradigm Shift in the Treatment of Tuberous Breast
BACKGROUND The tuberous breast syndrome is a condition that affects young women and can bring on serious disorders of self-esteem. There are numerous surgical techniques to correct this condition, but most of them include the use of breast implants to replace lack of volume. Nowadays, patients are increasingly becoming more demanding to get a definitive solution with minimal aesthetic sequelae...
متن کاملA Methodology for Paradigm Shift to Explain Sustainable University
The sustainable university concept is rooted in prevalent paradigms pertained to economic, social and environmental development, which all focus on systemic thought and rationality; besides, they tend to discover and solve problems by applying an interdisciplinary approach. However, the epistemic component is what these paradigms have ignored. The purpose of this study is to explain a methodo...
متن کاملParadigm Shift in Reconfigurable Computing
As per the Moore's law, the number of transistors that could be placed on a single integrated circuit has been increasing exponentially, and today has reached the stage where the implementation of multiple processor cores on a single chip has become a reality. As a result, the capacity of modern FPGA devices will soon support the implementation of hundreds to thousands of soft microprocessor co...
متن کاملBortezomib paradigm shift in myeloma.
Bortezomib (Velcade, formerly PS-341) is a peptide boronate inhibitor of the proteasome that was developed for cancer therapy by Julian Adams, Peter Elliott, and their colleagues.1 At the time, this was considered a very bold move, since loss of proteasome function was thought to be incompatible with viability in normal cells. However, using a novel assay that directly measures 20S proteasome a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer Research, Statistics, and Treatment
سال: 2020
ISSN: 2590-3233
DOI: 10.4103/crst.crst_333_20